What is required on every compounded drug supplied to a physician for direct patient administration?

In the context of compounded drugs supplied to a physician for direct patient administration, it is essential to include a "For direct patient administration only" label. This requirement clearly indicates that the compounded drug is intended for immediate use by a patient and not for retail distribution or any other purpose.

Such labeling is crucial for ensuring that healthcare professionals understand the specific use of these compounded medications. It helps to prevent misuse or misunderstanding about how the drug should be administered and reinforces that it is ready for patient care.

The other options, while they pertain to specific situations or contexts, do not appropriately reflect the intent or requirements for compounded drugs being administered directly to patients. For example, a controlled substance label is not necessary unless the compounded drug contains a controlled substance. Similarly, a manufacturer label is irrelevant for compounded medications, as they are not commercially manufactured products. The "For hospital administration only" label is more restrictive than what is required for compounded drugs intended for direct patient administration.

Therefore, the inclusion of the accurate and clear labeling as "For direct patient administration only" serves to promote safe and effective use of compounded medications in clinical practice.